XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments (Tables)
6 Months Ended
Oct. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Allocation of Share Based Compensation Expense
Stock-based compensation expense was recognized as follows (table in thousands):
 
 
Three Months Ended
October 31,
 
Six Months Ended
October 31,
 
2017
 
2016
 
2017
 
2016
General and administrative
$
96

 
$
469

 
$
519

 
$
1,298

Sales and marketing
7

 
18

 
41

 
187

Research and development
42

 
45

 
122

 
130

TOS cost of sales
3

 
3

 
28

 
47

POS cost of sales

 

 
1

 
2

Total stock-based compensation expense
$
148

 
$
535

 
$
711

 
$
1,664

Valuation Assumptions for Stock Options
Black-Scholes assumptions used to calculate the fair value of options granted during the three and six months ended October 31, 2017 and 2016 were as follows:
 
 
Three Months Ended
October 31,
 
Six Months Ended
October 31,
 
2017
 
2016
 
2017
 
2016
Expected term in years
6
 
6
 
6
 
2.6 - 6
Risk-free interest rates
1.98%
 
1.48%
 
1.98%
 
0.75% - 1.48%
Volatility
87.1%
 
87.32%
 
87.1%
 
73.2% - 95.6%
Dividend yield
—%
 
—%
 
—%
 
—%
Summary of Stock Option Activity
The Company’s stock options activity for the six months ended October 31, 2017 was as follows:
 
 
Non-
Employees
 
Directors
and
Employees
 
Total
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
Outstanding, May 1, 2017
50,000

 
2,258,704

 
2,308,704

 
$
2.86

 
6.1
 
$
1,282,000

Granted

 
194,977

 
194,977

 
2.51

 
9.7
 


Exercised

 

 

 

 
 
 
 

Forfeited

 
(6,042
)
 
(6,042
)
 
7.58

 
 
 
 

Canceled

 

 

 

 
 
 
 
Expired

 
(2,709
)
 
(2,709
)
 
8.44

 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
Outstanding, October 31, 2017
50,000

 
2,444,930

 
2,494,930

 
2.82

 
5.9
 
$
2,512,000

 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest as of October 31, 2017
50,000

 
2,444,930

 
2,494,930

 
2.82

 
5.9
 
$
2,512,000

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable as of October 31, 2017
33,336

 
2,391,889

 
2,425,225

 
2.81

 
5.9
 
$
2,484,000

Summary of Warrant Activity
Activity related to these warrants, which expire at various dates through March 2020, is summarized as follows:
 
Number
of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
Outstanding, May 1, 2017
2,004,284

 
$
5.57

 
2.8

 
$

Granted

 

 

 

Exercised

 

 

 

Expired

 

 

 

 
 
 
 
 
 
 
 
Outstanding, October 31, 2017
2,004,284

 
$
5.57

 
2.3

 
$